Titan Biotech Profit & Loss Annual

BSE: 524717 | NSE: - | ISIN: INE150C01011 | Sector: Biotechnology & Drugs

789.70 +24.20 (3.16%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Revenue	164.07	144.00	123.55	142.24
Total Revenue	164.07	144.00	123.55	142.24
Costof Revenue Total	75.61	83.36	68.53	64.57
Gross Profit	88.47	60.64	55.02	77.67
Selling/ General/ Admin Expenses Total	23.71	30.99	23.59	31.54
Depreciation/ Amortization	3.33	2.60	2.37	2.22
Other Operating Expenses Total	30.47	0.13	0.16	-
Total Operating Expense	133.12	117.08	94.65	98.65
Operating Income	30.95	26.92	28.90	43.59
Interest Inc( Exp) Net- Non- Op Total	-11.70	-3.57	-4.86	-14.20
Other Net	1.75	1.55	0.56	0.54
Net Income Before Taxes	31.53	28.12	28.97	42.71
Provisionfor Income Taxes	7.87	7.09	7.28	11.00
Net Income After Taxes	23.66	21.02	21.68	31.71
Minority Interest	0.00	-	-	-1.37
Equity In Affiliates	11.90	38.19	0.00	-
Net Income Before Extra Items	24.85	24.84	21.68	30.34
Net Income	24.85	24.84	21.68	30.34
Income Availableto Com Excl Extra Ord	24.85	24.84	21.68	30.34
Income Availableto Com Incl Extra Ord	24.85	24.84	21.68	30.34
Diluted Net Income	24.85	24.84	21.68	30.34
Diluted Weighted Average Shares	0.83	0.83	0.83	0.83
Diluted EPS Excluding Extra Ord Items	30.07	30.06	26.24	36.71
DPS- Common Stock Primary Issue	2.00	1.80	1.50	1.50
Diluted Normalized EPS	30.07	30.06	26.24	37.00
Gain( Loss)on Saleof Assets	-	0.00	-0.02	-0.03
Unusual Expense( Income)	-	-	-	0.32